In this study, our microarray analysis revealed that the gene expression of IGFBP-5, the parent protein of AMP-IBP5, is lower in skin lesions of patients with AD than in non-lesional skin, suggesting that AMP-IBP5 might be involved in AD pathogenesis. Here, IGFBP5 is linked to Alzheimer disease.